BFSG LLC’s Guardant Health GH Stock Holding History

BFSG LLC’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,676	Closed	-$812K	–	260
2023 Q2	$812K	Buy	+22,676	New	+$651K	0.14%	156

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFSG LLC's GH Position: Q3 2023 in Review

BFSG LLC sold out of Guardant Health (GH) in Q3 2023, closing a stake of 22,676 shares — an estimated $812K sold.

BFSG LLC first reported a position in GH in Q2 2023 and held it in 1 quarter. The position peaked at $812K in Q2 2023. 295 funds tracked by Wall St. Rank hold GH as of Q3 2023.

BFSG LLC reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
BFSG LLC sold 22,676 Guardant Health shares in Q3 2023, an estimated $812K.
BFSG LLC first reported a position in Guardant Health in Q2 2023 and held it in 1 quarter.
BFSG LLC's Guardant Health position peaked at $812K in Q2 2023.
295 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on BFSG LLC's 13F filing for Q3 2023, filed 20 Oct 2023.